全球多重檢測市場規模、佔有率、成長分析、依產品、類型、技術、應用 - 產業預測 2024-2031

2022年全球多重檢測市場規模約20.5億美元，預計將從2023年的23.5億美元增至2031年的70.8億美元，預測期內（2024-2031年）複合年成長率為14.77% 。

推動全球多重檢測市場的主要因素是傳染病和慢性病的盛行率不斷上升、多重檢測相對於單一多重檢測和傳統檢測的主要優勢、多重檢測在伴隨診斷中使用的成長以及早期診斷意識的不斷提高。

根據目前藥物核准情況預測，伴隨診斷預計將在不久的將來大幅擴展。例如，FDA 授權羅氏於 2021 年 8 月銷售伴隨診斷產品，以發現可從抗 PD-1 免疫療法中受益的患者的 dMMR 實體瘤。因此，伴隨診斷的擴展可以大大促進全球市場的成長。早期診斷可以提高許多慢性疾病患者的生活品質，包括癌症，其存活率可提高三倍。早期發現還可以降低長期疾病的成本並增加可獲得的治療範圍。

2021 年 7 月在 Avalere 發表的一份報告指出，當疾病擴散到身體其他部位並降低生存可能性時，36% 至 53% 的非小細胞肺癌、胃癌和胰腺癌患者被診斷患有第4 期癌症。如果非小細胞肺癌、胃癌和胰臟癌在早期被發現，5年存活率可以提高一倍。這些差異正在提高人們對早期疾病診斷價值的認知，並可能對整個預計時間內的市場成長產生重大影響。分子和蛋白質診斷中生物標記的驗證不斷增加，加上對自動化系統和高通量測試的需求不斷成長，將進一步帶來市場擴張的機會。

多種生物標記分析在神經系統疾病、自體免疫疾病和癌症的研究中有著廣泛的應用。隨著如此多的生物標記被發現和驗證，很可能會開發出新的診斷方法。多重測試可用於定量評估蛋白質，以識別生物標記。這些測定允許使用統計上顯著數量的樣品和對照來評估幾種潛在的蛋白質生物標記。因此，多重檢測在生物標記驗證中的應用提高了提供可靠資料的效率和速度，從而促進了短期市場擴張。

目錄

執行摘要

• 市場概況
• 命運之輪

研究方法論

• 資訊採購
• 二手和主要資料來源
• 市場規模估計
• 市場假設與限制

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題

主要市場洞察

• 技術分析
• 定價分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• 啟動分析
• 原料分析
• 創新矩陣
• 管道產品分析
• 總體經濟指標
• 頂級投資分析
• 成功的關鍵因素
• 競爭程度

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題
• 監管環境
• 波特分析
• 對未來顛覆的特別見解

依產品分類的全球多重檢測市場

• 市場概況
• 耗材
• 儀器和軟體

依類型分類的全球多重檢測市場

• 市場概況
• 蛋白質多重檢測
• 核酸多重檢測
• 基於細胞的多重檢測

依技術分類的全球多重檢測市場

• 市場概況
• 流式細胞儀
• 螢光偵測
• 發光
• 多重即時 PCR
• 其他技術

依應用分類的全球多重檢測市場

• 市場概況
• 研究和發展
• 和臨床診斷

依地區分類的全球多重檢測市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • MEA 的其餘部分

競爭格局

• 前 5 名企業比較
• 2021 年關鍵參與者的市場定位
• 主要市場參與者所採取的策略
• 最佳制勝策略
• 近期市集活動
• 主要公司市佔率（%），2021年

主要公司簡介

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Luminex Corporation
• Merck KGaA
• QIAGEN NV
• Roche Diagnostics
• Randox Laboratories Ltd.
• Bio-Techne Corporation
• Abcam plc
• GenScript Biotech Corporation
• Mesoscale Discovery, LLC
• Seegene Inc.
• Becton, Dickinson and Company
• Fluidigm Corporation
• Meso Scale Diagnostics, LLC
• PerkinElmer, Inc.
• Siemens Healthineers AG
• Biocartis NV

Global Multiplex Assay Market size was valued at around 2.05 billion in 2022 and is expected to rise from USD 2.35 billion in 2023 to reach a value of USD 7.08 Billion by 2031, at a CAGR of 14.77 % over the forecast period (2024-2031).

The primary factors driving the global multiplex assay market are the increasing prevalence of infectious and chronic diseases, the key benefits of multiplex assays over single plex and conventional assays, the growth of multiplex assay use in companion diagnostics, and the rising awareness of early diagnosis.

Predicted on current drug approval scenarios, companion diagnostics is expected to significantly expand in the near future. For example, the FDA authorized Roche to sell companion diagnostics in August 2021 to find dMMR solid tumors in patients who would benefit from anti-PD-1 immunotherapy. Therefore, the growth of the global market can be significantly aided by the expansion of companion diagnostics. Early diagnosis can enhance a patient's quality of life in many chronic diseases, including cancer, where there is a threefold increase in survival rate. Early detection can also reduce the cost of long-term illnesses and increase the spectrum of accessible therapies.

An report published in Avalere in July 2021 states that by the time the disease has spread to other body areas and decreased the likelihood of survival, between 36% and 53% of patients with non-small cell lung cancer, stomach cancer, and pancreatic cancer are diagnosed with stage 4 cancer. If non-small-cell lung cancer, stomach cancer, and pancreatic cancer are detected in their early stages, the 5-year survival rate can double. These differences are increasing awareness of the value of early disease diagnosis and could have a major impact on market growth throughout the projected period of time. The increasing validation of biomarkers in molecular and protein diagnostics, coupled with the growing demand for automated systems and high-throughput tests, will further present opportunities for market expansion.

Numerous applications of multiple biomarker analysis can be found in the research of neurological diseases, autoimmune diseases, and cancer. With so many biomarkers being discovered and validated, it is highly likely that new diagnoses will be developed. A multiplex test can be used to assess proteins quantitatively in order to identify biomarkers. These assays allow evaluation of several potential protein biomarkers using statistically significant quantities of samples and controls. As a result, the application of multiplex assays in biomarker validation improves the efficiency and speed at which reliable data may be delivered, thereby fostering short-term market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Multiplex Assay Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Multiplex Assay Market Segmental Analysis

The global multiplex assay market is segmented based on product, type, technology, application, process and region. Based on product the market is segmented into consumables, instruments and software. In terms of type, the market is segmented into protein multiplex assays, planar protein assays, bead-based protein assays, nucleic acid multiplex assays, planar protein assays, bead-based protein assays, and cell-based multiplex assays. Further classification of technology segments include flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies. Based on application the market is segmented into research & development and clinical diagnostics. Based on end-users the market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end-users. Based on region the global multiplex assay market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Multiplex Assay Market

Multiplex assay demand is being driven by the increasing need for personalized medication. Multiple biomarkers can be measured simultaneously with these assays, improving patient classification and enabling more individualized treatment choices.

Restraints in the Global Multiplex Assay Market

Multiplex assays' acceptance may be constrained by the regulatory issues they raise. Regulatory clearance for these assays is necessary, and it can be expensive and time-consuming.

Market Trends of the Global Multiplex Assay Market

Growing use of multiplex immunoassays: Because multiplex immunoassays can test many proteins in a single sample, there is a growing demand for these assays. Drug discovery, diagnostic testing, and biomarker identification all make extensive use of these assays.

Increasing use of microarrays: Because microarray technology can assess numerous analytes at once, it is becoming more and more popular in the multiplex assay market. Drug discovery, proteomics, and genomes all make extensive use of microarrays.

Next-generation sequencing (NGS) technology development: Because NGS technologies can sequence a large number of genes or DNA fragments at once, they are being used more often in multiplex experiments. Personalized medicine, diagnostic testing, and genomics research all make extensive use of NGS technologies.

Growing requirement for point-of-care testing (POCT): The need for quick and precise diagnostic testing is driving the demand for POCT. Because multiplex assays allow for the simultaneous detection of numerous analytes in a single sample, they are a good fit for point-of-care testing.

Precision medicine is becoming more and more popular. It is a new area that focuses on tailoring medical care to a patient's genetic composition, lifestyle, and surroundings. Precision medicine benefits greatly from multiplex assays since they allow for the evaluation of several biomarkers in one sample, resulting in individualized treatment options.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Multiplex Assay Market by Product

• Market Overview
• Consumables
• Instruments and Software

Global Multiplex Assay Market by Type

• Market Overview
• Protein Multiplex Assays
• Nucleic Acid Multiplex Assays
• Cell-based Multiplex Assays

Global Multiplex Assay Market by Technology

• Market Overview
• Flow Cytometry
• Fluorescence Detection
• Luminescence
• Multiplex Real-time PCR
• and Other Technologies

Global Multiplex Assay Market by Application

• Market Overview
• Research & Development
• and Clinical Diagnostics

Global Multiplex Assay Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoscale Discovery, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meso Scale Diagnostics, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocartis NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments